Yeruusaalem, 24 Agoosto, 2026 (TPS-IL) — Shirkadda qalabka caafimaadka ee Israa’iil ee IceCure Medical ayaa heshiis gaar ah la saxiixatay shirkadda Scovas Medical oo fadhigeedu yahay Netherlands, si ay u qaybiso nidaamyadeeda cryoablation ee ProSense dalka Netherlands.
ProSense wuxuu isticmaalaa nitrogen-ka dareeraha ah si uu u qaboojiyo uguna burburiyo burooyinka, taasoo ah beddelka qalliinka oo ah mid aan u baahnayn qalliin weyn.
Heshiiska ayaa yimid iyadoo maxkamadda kansarka naasaha ee THERMAC oo fadhigeedu yahay Netherlands ay gasho heerka III, taasoo diiradda saareysa cryoablation-ka qaar ka mid ah bukaanada qaba kansarka naasaha ee heerka hore. IceCure ayaa sheegtay in natiijooyinkii hore ee maxkamadda ay muujiyeen in ProSense uu gaaray heerka 94% ee burburinta buuxda, iyadoo aan lahayn wax dhibaato ah oo la soo weriyay iyo baahi loo qabo suuxinta guud.
Scovas waxay qaybin doontaa nidaamyada waxayna siin doontaa taageero caafimaad xirfadlayaasha daryeelka caafimaadka ee Nederlaan. IceCure ayaa sheegtay in heshiisku uu kordhin doono helitaanka ProSense wuxuuna taageeri doonaa kobocgiisa Yurub.